Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-007195

BIOGEN INC. · BIIB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael D Ehlers
Officer — EVP, Research and Development
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 15, 2018M1,712$0.00A5,407D
Common StockFeb 15, 2018F509$299.38D4,898D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF2$0.00Feb 15, 2018M1,712D—Feb 15, 2020Common Stock1,7126,448D
Restricted Stock UnitF3,F2$0.00Feb 15, 2018J1,006D—Feb 15, 2020Common Stock1,0065,442D

Explanation of responses